Literature DB >> 14530844

Necrotizing fasciitis after tension-free vaginal tape (TVT) placement.

Dallas W Johnson1, May ElHajj, Erin L OBrien-Best, Harold J Miller, Paul M Fine.   

Abstract

A 62-year-old homemaker underwent an uneventful TVT (tension-free vaginal tape) procedure. Eleven days postoperatively she presented to the Emergency Department with agonizing low abdominal pain, elbow pain, fever, and drainage from her suprapubic puncture sites. Her evaluation was consistent with a diagnosis of necrotizing fasciitis and she was started on antibiotics and taken to surgery for exploration and debridement, where the diagnosis was confirmed. This is the first report of necrotizing fasciitis following TVT placement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530844     DOI: 10.1007/s00192-003-1064-1

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  5 in total

1.  Necrotizing fasciitis: CT characteristics.

Authors:  M G Wysoki; T A Santora; R M Shah; A C Friedman
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

2.  Necrotizing soft tissue infections. Risk factors for mortality and strategies for management.

Authors:  D C Elliott; J A Kufera; R A Myers
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

3.  Burch colposuspension and tension-free vaginal tape in the management of stress urinary incontinence in women.

Authors:  A Liapis; P Bakas; G Creatsas
Journal:  Eur Urol       Date:  2002-04       Impact factor: 20.096

4.  Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence.

Authors:  U Ulmsten; P Petros
Journal:  Scand J Urol Nephrol       Date:  1995-03

5.  Necrotizing fasciitis in gynecologic and obstetric patients: a surgical emergency.

Authors:  Donald G Gallup; Murray A Freedman; Ramon V Meguiar; Sandra N Freedman; Thomas E Nolan
Journal:  Am J Obstet Gynecol       Date:  2002-08       Impact factor: 8.661

  5 in total
  9 in total

1.  Posterior rectus abdominis sheath abscess after tension-free vaginal tape.

Authors:  Christina A Ogle; Jonathan P Shepherd; Gary Sutkin
Journal:  Int Urogynecol J       Date:  2012-03-20       Impact factor: 2.894

2.  Tension-free vaginal tape exposure presenting as a recurrent sterile paraurethral abscess.

Authors:  Susan B Tate; Anna Virginia M Franco; Michelle M Fynes
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-04-22

Review 3.  Severe soft tissue infection of the thigh after vaginal erosion of transobturator tape for stress urinary incontinence.

Authors:  Gilles Karsenty; Jason Boman; Ehab Elzayat; Marie-Claude Lemieux; Jacques Corcos
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-05-24

Review 4.  Stress incontinence.

Authors:  Joseph Loze Onwude
Journal:  BMJ Clin Evid       Date:  2009-04-14

Review 5.  Safety considerations for synthetic sling surgery.

Authors:  Jerry G Blaivas; Rajveer S Purohit; Matthew S Benedon; Gabriel Mekel; Michael Stern; Mubashir Billah; Kola Olugbade; Robert Bendavid; Vladimir Iakovlev
Journal:  Nat Rev Urol       Date:  2015-08-18       Impact factor: 14.432

Review 6.  Mini-invasive tension-free surgery for female urinary incontinence.

Authors:  V Leanza; E Intagliata; F Ferla; A Leanza; M A Cannizzaro; R Vecchio
Journal:  G Chir       Date:  2014 Jan-Feb

Review 7.  Urethral slings placed by the transobturator approach: evolution in the technique and review of the literature.

Authors:  Alan W Shindel; Carl G Klutke
Journal:  Curr Urol Rep       Date:  2005-09       Impact factor: 2.862

Review 8.  Management of complications after tension-free midurethral slings.

Authors:  Bülent Cetinel; Tufan Tarcan
Journal:  Korean J Urol       Date:  2013-10-15

Review 9.  Update on complications of synthetic suburethral slings.

Authors:  Cristiano Mendes Gomes; Fabrício Leite Carvalho; Carlos Henrique Suzuki Bellucci; Thiago Souto Hemerly; Fábio Baracat; Jose de Bessa; Miguel Srougi; Homero Bruschini
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.